GE HealthCare Technologies Inc. Common Stock (GEHC) Valuation
Historical valuation analysis based on 950 data points (2023-01-04 to 2026-10-16)
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), adv...
GE HealthCare Technologies Inc. Common Stock (GEHC) currently trades at a P/E ratio of 15.83 (historical range: 8.53–27.02, median: 17.61), placing it at the 33th percentile — below its historical average, P/S ratio of 1.48 (range: 0.99–2.23, 17th percentile — cheap relative to its history), EV/EBITDA of 14.13 (range: 8.63–20.38, 18th percentile).
Over the historical period (2023-01-04 to 2026-10-16), GE HealthCare Technologies Inc. Common Stock's P/E ratio has contracted by 15% over the observed period (from an average of 20.0 to 16.9).
GE HealthCare Technologies Inc. Common Stock trades well below its historical valuation range across most metrics.
Historical Valuation Metrics
| Metric | Current | Median | %ile | Assessment |
|---|---|---|---|---|
| P/E Ratio | 15.83 | 17.61 | 33th | below its historical average |
| P/S Ratio | 1.48 | 1.78 | 17th | cheap relative to its history |
| EV/EBITDA | 14.13 | 16.13 | 18th | cheap relative to its history |
| FCF Yield | 5.02% | 4.56% | 76th | below its historical average |
GE HealthCare Technologies Inc. Common Stock (GEHC) Valuation & P/E History
GE HealthCare Technologies Inc. Common Stock (GEHC) is a US-listed stock operating in the Healthcare sector, specifically the X-Ray Apparatus & Tubes & Related Irradiation Apparatus industry currently trading at $69.57 with a market capitalization of $31.4 billion. This page provides historical valuation analysis for GEHC based on 950 data points covering 2023-01-04 to 2026-10-16. The P/E ratio of 15.83 is below the historical median of 17.61, placing GEHC at the 33th percentile of its valuation range. The P/S ratio of 1.48 compares to a median of 1.78.
GEHC Valuation Metrics & Historical Range
The valuation table above shows GE HealthCare Technologies Inc. Common Stock's current and historical valuation multiples, including P/E ratio, P/S ratio, EV/EBITDA, FCF yield, and dividend yield. Each metric is compared to its own historical range to determine whether GEHC is currently trading above or below its typical valuation levels.
- P/E ratio: Price-to-earnings measures how much investors pay per dollar of earnings. A P/E above the historical median suggests GEHC is expensively valued; below the median suggests it is cheap.
- P/S ratio: Price-to-sales is useful for companies with volatile or negative earnings. Lower P/S relative to history may indicate value.
- EV/EBITDA: Enterprise value to EBITDA adjusts for debt and cash, providing a capital-structure-neutral valuation measure for GE HealthCare Technologies Inc. Common Stock.
- FCF yield: Free cash flow yield shows the cash return relative to market price. Higher yields may indicate undervaluation.
Is GEHC Overvalued or Undervalued?
GE HealthCare Technologies Inc. Common Stock trades well below its historical valuation range across most metrics. The overall valuation percentile of 23 combines P/E, P/S, and EV/EBITDA percentiles into a single measure of how expensive GEHC is relative to its own history. A percentile below 25 suggests the stock may be undervalued, while a percentile above 75 suggests it may be overvalued.
However, valuation is only one factor in investment decisions. A stock can remain "overvalued" for years if growth accelerates, or "undervalued" if the business deteriorates. Always combine valuation analysis with financial statement analysis and the full GEHC analysis page for a complete picture.
Valuation data is computed from historical price and fundamental data via Polygon.io and Finnhub.GEHC trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.